Saturday, February 19, 2011

Sanofi-Aventis Finally Buys Genzyme

Image: joanneQescober/Flickr After six months of negotiations, French drug giant Sanofi-Aventis has picked up Genzyme, which specializes in the treatment of rare diseases, for roughly $20 billion. FiercePharma's Tracy Staton sums up the deal:... Read more

Garcelle Beauvais Kristy Swanson Ali Campoverdi Giuliana DePandi Pamela Anderson

No comments:

Post a Comment